Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-20 11:14 am Sale | 2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX | Empery Asset Management, LP | 1,329 4.570% | -338 (-20.27%) | Filing History |
| 2021-01-20 11:11 am Unchanged | 2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Empery Asset Management, LP | 44 4.990% | 0 (Unchanged) | Filing History |
| 2021-01-20 11:10 am Sale | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management, LP | 336 1.050% | -1,664 (-83.21%) | Filing History |
| 2021-01-20 11:08 am Purchase | 2020-12-31 | 13G | Hancock Jaffe Laboratories HJLI | Empery Asset Management, LP | 185,868 4.990% | 185,868 (New Position) | Filing History |
| 2021-01-20 11:05 am Purchase | 2020-12-31 | 13G | Genius Brands International, Inc. GNUS | Empery Asset Management, LP | 1,000,000 3.750% | 67,143 (+7.20%) | Filing History |
| 2021-01-20 11:03 am Purchase | 2020-12-31 | 13G | Globus Maritime Limited GLBS | Empery Asset Management, LP | 372,494 4.990% | 372,494 (New Position) | Filing History |
| 2021-01-20 11:01 am Sale | 2020-12-31 | 13G | Second Sight Medical Products, Inc. EYES | Empery Asset Management, LP | 0 0.000% | -733,333 (Position Closed) | Filing History |
| 2021-01-19 09:58 am Purchase | 2021-01-14 | 13G | Viveve Medical, Inc. VIVE | Empery Asset Management, LP | 1,029,411 9.960% | 1,029,411 (New Position) | Filing History |
| 2021-01-14 09:02 am Purchase | 2021-01-10 | 13G | Applied DNA Sciences, Inc. APDN | Empery Asset Management, LP | 32 6.420% | 32 (+6880.80%) | Filing History |
| 2021-01-14 09:00 am Purchase | 2021-01-08 | 13G | Zevra Therapeutics, Inc. ZVRA | Empery Asset Management, LP | 1,230,000 9.990% | 1,230,000 (New Position) | Filing History |
| 2021-01-14 09:00 am Purchase | 2021-01-06 | 13G | Atossa Therapeutics, Inc. ATOS | Empery Asset Management, LP | 4,760,500 5.320% | 4,760,500 (New Position) | Filing History |
| 2021-01-13 09:03 am Purchase | 2020-12-31 | 13G | Castor Maritime Inc. CTRM | Empery Asset Management, LP | 277,333 9.910% | 130,000 (+88.24%) | Filing History |
| 2021-01-13 09:03 am Sale | 2020-12-31 | 13G | CELLECT BIOTECHNOLOGY LTD SPON APOP | Empery Asset Management, LP | 185,200 0.050% | -32,114,800 (-99.43%) | Filing History |
| 2021-01-13 09:02 am Sale | 2020-12-31 | 13G | Allena Pharmaceuticals, Inc. ALNAQ | Empery Asset Management, LP | 0 0.000% | -2,792,683 (Position Closed) | Filing History |
| 2021-01-13 09:02 am Unchanged | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Empery Asset Management, LP | 10,222 4.990% | 0 (Unchanged) | Filing History |
| 2021-01-13 09:01 am Purchase | 2020-12-31 | 13G | Baudax Bio, Inc. BXRX | Empery Asset Management, LP | 714 2.600% | 714 (New Position) | Filing History |
| 2021-01-13 09:01 am Purchase | 2020-12-31 | 13G | Nuwellis, Inc. NUWE | Empery Asset Management, LP | 3 4.990% | 3 (New Position) | Filing History |
| 2021-01-13 09:00 am Sale | 2020-12-31 | 13G | Aethlon Medical, Inc. AEMD | Empery Asset Management, LP | 1,031 4.990% | -270 (-20.74%) | Filing History |
| 2021-01-07 12:47 pm Purchase | 2020-12-31 | 13G | Orbital Infrastructure Group, Inc. OIG | Empery Asset Management, LP | 46,296 5.110% | 46,296 (New Position) | Filing History |